mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.27 |
5e-13 |
mRNA |
FK866 |
GDSC1000 |
pan-cancer |
AAC |
0.24 |
1e-12 |
mRNA |
Genentech Cpd 10 |
GDSC1000 |
pan-cancer |
AAC |
0.25 |
3e-12 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.26 |
3e-12 |
mRNA |
Docetaxel |
GDSC1000 |
pan-cancer |
AAC |
-0.24 |
8e-12 |
mRNA |
BRD-K34222889 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
8e-12 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
1e-11 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.26 |
1e-11 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
2e-11 |
mRNA |
GSK690693 |
GDSC1000 |
pan-cancer |
AAC |
0.25 |
2e-11 |